Published in Eukaryot Cell on June 01, 2004
Sphingosine 1-phosphate lyase, a key regulator of sphingosine 1-phosphate signaling and function. Adv Enzyme Regul (2009) 1.26
Sphingosine-1-phosphate lyase in development and disease: sphingolipid metabolism takes flight. Biochim Biophys Acta (2008) 1.06
Lyase to live by: sphingosine phosphate lyase as a therapeutic target. Expert Opin Ther Targets (2009) 1.02
S1P lyase regulates DNA damage responses through a novel sphingolipid feedback mechanism. Cell Death Dis (2011) 0.95
Sphingosine kinase regulates the sensitivity of Dictyostelium discoideum cells to the anticancer drug cisplatin. Eukaryot Cell (2005) 0.93
S1P metabolism in cancer and other pathological conditions. Biochimie (2010) 0.92
The role of sphingosine-1-phosphate in breast cancer tumor-induced lymphangiogenesis. Lymphat Res Biol (2012) 0.92
Still benched on its way to the bedside: sphingosine kinase 1 as an emerging target in cancer chemotherapy. Crit Rev Biochem Mol Biol (2011) 0.91
Sphingolipid signaling and hematopoietic malignancies: to the rheostat and beyond. Anticancer Agents Med Chem (2011) 0.88
Global transcriptional responses to cisplatin in Dictyostelium discoideum identify potential drug targets. Proc Natl Acad Sci U S A (2007) 0.88
Pharmacogenetics of resistance to Cisplatin and other anticancer drugs and the role of sphingolipid metabolism. Methods Mol Biol (2013) 0.75
5-fluorouracil: mechanisms of action and clinical strategies. Nat Rev Cancer (2003) 11.78
Cisplatin: mode of cytotoxic action and molecular basis of resistance. Oncogene (2003) 10.74
Cultivation and synchronous morphogenesis of Dictyostelium under controlled experimental conditions. Methods Cell Biol (1987) 6.62
Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate. Nature (1996) 5.48
Tagging developmental genes in Dictyostelium by restriction enzyme-mediated integration of plasmid DNA. Proc Natl Acad Sci U S A (1992) 3.93
Discovery and evaluation of inhibitors of human sphingosine kinase. Cancer Res (2003) 3.71
Mechanisms of resistance to cisplatin. Mutat Res (2001) 3.51
Uptake of the anticancer drug cisplatin mediated by the copper transporter Ctr1 in yeast and mammals. Proc Natl Acad Sci U S A (2002) 3.28
The ATP-dependent glutathione S-conjugate export pump. Trends Biochem Sci (1992) 3.22
The role of glutathione-S-transferase in anti-cancer drug resistance. Oncogene (2003) 3.10
Activation of sphingosine kinase 1 by ERK1/2-mediated phosphorylation. EMBO J (2003) 2.93
De novo sphingolipid biosynthesis: a necessary, but dangerous, pathway. J Biol Chem (2002) 2.79
Sphingosine kinase, sphingosine-1-phosphate, and apoptosis. Biochim Biophys Acta (2002) 2.53
Sphingosine 1-phosphate, a key cell signaling molecule. J Biol Chem (2002) 2.42
The Dictyostelium developmental cDNA project: generation and analysis of expressed sequence tags from the first-finger stage of development. DNA Res (1998) 2.03
Cloning vectors for the production of proteins in Dictyostelium discoideum. Gene (1995) 2.02
Phenoxodiol--an isoflavone analog--induces apoptosis in chemoresistant ovarian cancer cells. Oncogene (2003) 1.65
The copper transporter CTR1 regulates cisplatin uptake in Saccharomyces cerevisiae. Mol Pharmacol (2002) 1.62
Retracted AKT2 inhibition of cisplatin-induced JNK/p38 and Bax activation by phosphorylation of ASK1: implication of AKT2 in chemoresistance. J Biol Chem (2003) 1.49
Sphingosine kinase type 1 induces G12/13-mediated stress fiber formation, yet promotes growth and survival independent of G protein-coupled receptors. J Biol Chem (2003) 1.47
Role of the p38 MAPK pathway in cisplatin-based therapy. Oncogene (2003) 1.41
cAMP signaling in Dictyostelium. Complexity of cAMP synthesis, degradation and detection. J Muscle Res Cell Motil (2002) 1.32
Sphingosine-phosphate lyase enhances stress-induced ceramide generation and apoptosis. J Biol Chem (2003) 1.32
Role for de novo sphingoid base biosynthesis in the heat-induced transient cell cycle arrest of Saccharomyces cerevisiae. J Biol Chem (2000) 1.25
Sply regulation of sphingolipid signaling molecules is essential for Drosophila development. Development (2003) 1.22
Sphingosine 1-phosphate signaling: providing cells with a sense of direction. Trends Cell Biol (2002) 1.20
Sphingosine-phosphate lyase. Adv Lipid Res (1993) 1.10
Molecular basis for resistance to the anticancer drug cisplatin in Dictyostelium. Microbiology (2000) 1.10
Sphingosine-1-phosphate lyase is involved in the differentiation of F9 embryonal carcinoma cells to primitive endoderm. J Biol Chem (2003) 1.10
The DPL1 gene is involved in mediating the response to nutrient deprivation in Saccharomyces cerevisiae. Mol Cell Biol Res Commun (1999) 1.06
Sphingosine phosphate lyase expression is essential for normal development in Caenorhabditis elegans. J Biol Chem (2003) 1.03
A genome-wide screening in Saccharomyces cerevisiae for genes that confer resistance to the anticancer agent cisplatin. Biochem Biophys Res Commun (2000) 1.00
Sphingosine kinase mediates cyclic AMP suppression of apoptosis in rat periosteal cells. Mol Pharmacol (1998) 0.99
Sphingosine-1-phosphate lyase has a central role in the development of Dictyostelium discoideum. Development (2001) 0.95
The extrachromosomal replication of Dictyostelium plasmid Ddp2 requires a cis-acting element and a plasmid-encoded trans-acting factor. Mol Cell Biol (1990) 0.92
Depletion of protein kinase C (PKC) by 12-O-tetradecanoylphorbol-13-acetate (TPA) enhances platinum drug sensitivity in human ovarian carcinoma cells. Br J Cancer (2000) 0.89
Novel soluble cationic trans-diaminedichloroplatinum(II) complexes that are active against cisplatin resistant ovarian cancer cell lines. J Med Chem (2002) 0.84
Viability assay for Dictyostelium for use in drug studies. Biotechniques (2003) 0.83
Cellular signaling by sphingosine and sphingosine 1-phosphate. Their opposing roles in apoptosis. Subcell Biochem (2002) 0.81
Sphingosine 1-phosphate and cell migration: resistance to angiogenesis inhibitors. Biochem Biophys Res Commun (2003) 0.78
Biomechanics of the human posterior sclera: age- and glaucoma-related changes measured using inflation testing. Invest Ophthalmol Vis Sci (2012) 1.89
(Dihydro)ceramide synthase 1 regulated sensitivity to cisplatin is associated with the activation of p38 mitogen-activated protein kinase and is abrogated by sphingosine kinase 1. Mol Cancer Res (2007) 1.25
Towards a molecular understanding of human diseases using Dictyostelium discoideum. Trends Mol Med (2006) 1.22
Proteomic analysis to identify breast cancer biomarkers in nipple aspirate fluid. Clin Cancer Res (2004) 1.19
Sphingosine-1-phosphate lyase regulates sensitivity of human cells to select chemotherapy drugs in a p38-dependent manner. Mol Cancer Res (2005) 1.17
Regulatory T-cell recovery in recipients of haploidentical nonmyeloablative hematopoietic cell transplantation with a humanized anti-CD2 mAb, MEDI-507, with or without fludarabine. Exp Hematol (2007) 1.07
Ceramide synthase 1 is regulated by proteasomal mediated turnover. Biochim Biophys Acta (2009) 0.95
Sphingosine kinase regulates the sensitivity of Dictyostelium discoideum cells to the anticancer drug cisplatin. Eukaryot Cell (2005) 0.93
Sphingosine 1-phosphate-metabolizing enzymes control influenza virus propagation and viral cytopathogenicity. J Virol (2010) 0.93
Quantitative real-time polymerase chain reaction for the verification of genomic imbalances detected by microarray-based comparative genomic hybridization. Genet Test Mol Biomarkers (2009) 0.91
Minimal preconditioning effects observed for inflation tests of planar tissues. J Biomech Eng (2013) 0.91
Global transcriptional responses to cisplatin in Dictyostelium discoideum identify potential drug targets. Proc Natl Acad Sci U S A (2007) 0.88
Stress-induced ER to Golgi translocation of ceramide synthase 1 is dependent on proteasomal processing. Exp Cell Res (2009) 0.87
Gold nanoparticle-mediated detection of circulating cancer cells. Clin Lab Med (2012) 0.86
Does cytokine signaling link sphingolipid metabolism to host defense and immunity against virus infections? Cytokine Growth Factor Rev (2011) 0.84
Viability assay for Dictyostelium for use in drug studies. Biotechniques (2003) 0.83
Methanol and acriflavine resistance in Dictyostelium are caused by loss of catalase. Microbiology (2002) 0.83
Sphingosine-1-phosphate plays a role in the suppression of lateral pseudopod formation during Dictyostelium discoideum cell migration and chemotaxis. Cell Motil Cytoskeleton (2004) 0.82
The Dictyostelium discoideum prespore-specific catalase B functions to control late development and to protect spore viability. Biochim Biophys Acta (2003) 0.81
Sphingosine kinase 1 serves as a pro-viral factor by regulating viral RNA synthesis and nuclear export of viral ribonucleoprotein complex upon influenza virus infection. PLoS One (2013) 0.81
Dictyostelium discoideum to human cells: pharmacogenetic studies demonstrate a role for sphingolipids in chemoresistance. Biochim Biophys Acta (2005) 0.80
Proteomics of canine lymphoma identifies potential cancer-specific protein markers. Clin Cancer Res (2007) 0.80
Lead genetic studies in Dictyostelium discoideum and translational studies in human cells demonstrate that sphingolipids are key regulators of sensitivity to cisplatin and other anticancer drugs. Semin Cell Dev Biol (2010) 0.79
Sensitive cell viability assay for use in drug screens and for studying the mechanism of action of drugs in Dictyostelium discoideum. Biotechniques (2006) 0.77
Pharmacogenetics of resistance to Cisplatin and other anticancer drugs and the role of sphingolipid metabolism. Methods Mol Biol (2013) 0.75
Induction Therapy, Rejection, and Graft Outcomes in Pediatric and Adolescent Kidney Transplant Recipients. Transplantation (2017) 0.75
Proteomics opens doors to the mechanisms of developmentally regulated secretion. Mol Cell Proteomics (2003) 0.75